Mereo Biopharma Group Ltd. buy BiotechBee
Start price
23.06.24
/
50%
€3.81
Target price
30.11.26
€5.00
Performance (%)
-1.31%
End price
16.09.24
€3.76
Summary
This prediction ended on 16.09.24 with a price of €3.76. With a performance of -1.31%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has a follow-up prediction for Mereo Biopharma Group Ltd. where he still thinks Mereo Biopharma Group Ltd. is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Mereo Biopharma Group Ltd. | - | - |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
According to BiotechBee what are the pros and cons of Mereo Biopharma Group Ltd. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Mereo Biopharma Group Ltd. diskutieren
Buy mit Kursziel 5,0
In the thread Trading Mereo Biopharma Group Ltd.
Buy beendet
Current prediction by BiotechBee for Mereo Biopharma Group Ltd.
Mereo Biopharma Group Ltd.
Start price
Target price
Perf. (%)
€3.76
16.09.24
16.09.24
€5.00
30.04.27
30.04.27
6.91%
04.10.24
04.10.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Mereo Biopharma Group Ltd.
Mereo Biopharma Group Ltd.
Start price
Target price
Perf. (%)
€0.83
11.01.23
11.01.23
€2.00
31.12.25
31.12.25
32.53%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year